OncoTherapy Science (30O) Revenue

0 Followers

OncoTherapy Science Revenue

OncoTherapy Science had a revenue of 186.75M in the quarter ending Mar 31, 2025, with -44.75%. This bring the company's revenue in the last twelve months to 749.75M, Decreased 6.03%. In the fiscal year ending Mar 31, 2026, OncoTherapy Science had annual revenue of 808.53M with 7.80% growth.

Revenue (ttm)

749.75M

Revenue Growth

-17.22%

P/S Ratio

0.07

Revenue/Employee

€17,576,739

Employees

Market Cap

€52.69M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	808.53M	58.48M	+7.80%
Mar 31, 2025	750.05M	139.93M	+22.93%
Mar 31, 2024	610.12M	-524.78M	-46.24%
Mar 31, 2022	1.13B	802.43M	+241.35%
Mar 31, 2021	332.48M	-821.19M	-71.18%
Mar 31, 2021	1.15B	837.45M	+264.84%
Mar 31, 2020	316.21M	35.63M	+12.70%
Mar 31, 2019	280.59M	69.33M	+32.82%
Mar 31, 2018	211.25M	―	―